Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy
/in International Publications, Newcastle Disease Virus /von 2007-10-04 / Gene Ther. 2007 Dec;14(23):1639-49Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 2007-09-01 / Cancer Res. 2007 Sep;67(17):8285-92In vitro induction of apoptosis in tumor cells by inactivated NDV and IAV
/in International Publications, Newcastle Disease Virus /von 2007-04-01 / Cancer Biother. Radiopharm. 2007 Apr;22(2):200-5Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 2007-03-01 / Curr Cancer Drug Targets 2007 Mar;7(2):157-67Oncolytic virus therapy–foreword
/in International Publications, Newcastle Disease Virus /von 2007-03-01 / Curr Cancer Drug Targets 2007 Mar;7(2):123-5Systemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions
/in International Publications, Newcastle Disease Virus /von 2007-01-15 / Cancer Res. 2007 Jan;67(2):429-32p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2007-01-10 / J. Virol. 2007 Mar;81(6):2817-30Combined treatment of pediatric high-grade glioma with the oncolytic viral strain MTH-68/H and oral valproic acid
/in Brain Tumors in Children, Glioblastoma, International Publications, Newcastle Disease Virus /von 2006-10-01 / APMIS 2006 Oct;114(10):731-43Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death
/in International Publications, Newcastle Disease Virus /von 2006-08-01 / J. Virol. 2006 Aug;80(15):7522-34
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de